Silo Pharma Stock (NASDAQ:SILO)


RevenueOwnershipFinancialsChart

Previous Close

$1.05

52W Range

$0.84 - $4.50

50D Avg

$1.13

200D Avg

$1.52

Market Cap

$4.75M

Avg Vol (3M)

$220.87K

Beta

1.39

Div Yield

-

SILO Company Profile


Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

3

IPO Date

Jan 08, 2021

Website

SILO Performance


SILO Financial Summary


Dec 23Dec 22Dec 21
Revenue$72.10K$72.10K$71.26K
Operating Income$-3.86M$-3.65M$-2.74M
Net Income$-3.70M$-3.91M$3.90M
EBITDA$-3.86M$-3.58M$-2.89M
Basic EPS$-1.20$-1.71$2.06
Diluted EPS$-1.20$-1.71$2.03

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison


TickerCompany
IVAInventiva S.A.
DAWNDay One Biopharmaceuticals, Inc.
IPSCCentury Therapeutics, Inc.
HOOKHOOKIPA Pharma Inc.
CSBRChampions Oncology, Inc.
TERNTerns Pharmaceuticals, Inc.
INZYInozyme Pharma, Inc.
ABOSAcumen Pharmaceuticals, Inc.
RZLTRezolute, Inc.
INDPIndaptus Therapeutics, Inc.
TPSTTempest Therapeutics, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
URGNUroGen Pharma Ltd.
BCDABioCardia, Inc.
PRDSPardes Biosciences, Inc.
FBRXForte Biosciences, Inc.
STTKShattuck Labs, Inc.
LUMOLumos Pharma, Inc.
ELYMEliem Therapeutics, Inc.